Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: A novel marker for predicting preeclampsia

Hypertension

Volumn 59, Issue 2, 2012, Pages 265-273

  Takizawa, Toshihiro ^a   Ishibashi, Osamu ^a   Ohkuchi, Akihide ^b   Moksed Ali, Md ^a   Kurashina, Ryuhei ^a   Luo, Shan Shun ^c   Ishikawa, Tomoko ^a   Takizawa, Takami ^a   Hirashima, Chikako ^b   Takahashi, Kayo ^b   Migita, Makoto ^a   Ishikawa, Gen ^a   Yoneyama, Koichi ^a   Asakura, Hirobumi ^a   Izumi, Akio ^b   Matsubara, Shigeki ^b   Takeshita, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; MicroRNA; Placenta; Preeclampsia; Prospective cohort study

Indexed keywords

17 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1; LUCIFERASE; MICRORNA; MICRORNA 210; MICRORNA 518C; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC CODE; GESTATIONAL AGE; HUMAN; IN VIVO STUDY; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; ANOXIA; BIOLOGICAL MARKERS; CELLS, CULTURED; COHORT STUDIES; ESTRADIOL DEHYDROGENASES; FEMALE; HUMANS; MICRORNAS; PLACENTA; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; TROPHOBLASTS;

EID: 84856277270     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.180232     Document Type: Article

References (28)

1. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970-975. (Pubitemid 351398986)
2. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J Reprod Immunol. 2009;82:106-111.
3. Tjoa ML, Levine RJ, Karumanchi SA. Angiogenic factors and preeclampsia. Front Biosci. 2007;12:2395-2402.
4. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009:147-158.
5. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
6. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233.
7. Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell. 2008;29:1-7.
8. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foà R, Schliwka J, Fuchs U, Novosel A, Müller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401-1414. (Pubitemid 46970709)
9. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37:766-770. (Pubitemid 41754896)
10. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, Ohkuchi A, Matsubara S, Takeshita T, Takizawa T. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod. 2009;81:717-729.
11. Hu Y, Li P, Hao S, Liu L, Zhao J, Hou Y. Differential expression of microRNAs in the placentae of Chinese patients with severe preeclampsia. Clin Chem Lab Med. 2009;47:923-929.
12. Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009;200:661.e1-661.e7.
13. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P, Hassan SS, Kim CJ. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007;196:261.e1-261.e6.
14. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008;14:844-852. (Pubitemid 351574906)
15. Massart C, Le Pogamp C, Nicol M. Plasma hormone concentrations and serum 17 β-hydroxysteroid dehydrogenase activity in molar pregnancy. Clin Chem. 1982;28:1474-1477. (Pubitemid 12090686)
16. Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H, Hu Y. MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol. 2010;202:466.e1-466.e7.
17. Takeyama J, Suzuki T, Hirasawa G, Muramatsu Y, Nagura H, Iinuma K, Nakamura J, Kimura KI, Yoshihama M, Harada N, Andersson S, Sasano H. 17β-Hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus. J Clin Endocrinol Metab. 2000;85:410-416. (Pubitemid 32268844)
18. Bonenfant M, Provost PR, Drolet R, Tremblay Y. Localization of type 1 17β-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi. J Endocrinol. 2000;165:217-222. (Pubitemid 30341070)
19. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150:452-462.
20. Mathew LK, Simon MC. mir-210: a sensor for hypoxic stress during tumorigenesis. Mol Cell. 2009;35:737-738.
21. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des. 2009;15:3861-3866.
22. Huang X, Le QT, Giaccia AJ. MiR-210-micromanager of the hypoxia pathway. Trends Mol Med. 2010;16:230-237.
23. Ivan M, Harris AL, Martelli F, Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med. 2008;12:1426-1431.
24. Peltoketo H, Isomaa V, Poutanen M, Vihko R. Expression and regulation of 17 β-hydroxysteroid dehydrogenase type 1. J Endocrinol. 1996;150(suppl S): 21-30.
25. Peltoketo H, Vihko P, Vihko R. Regulation of estrogen action: role of 17 β-hydroxysteroid dehydrogenases. Vitam Horm. 1999;55:353-398.
26. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007;197:244.e1-244.e8.
27. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2010;355:992-1005. (Pubitemid 44343543)
28. Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene. 2010;29:2161-2164.